HPV Pathway Profiling: HPV Related Cervical Dysplasia and Carcinoma Studies

被引：0
|
作者：
Scholl, Susy M. [1 ]
Kamal, Maud [1 ]
De Koning, Leanne [1 ]
Kereszt, Attila [2 ]
Jordanova, Ekaterina S. [3 ]
Ungureanu, Sergiu [4 ]
Berns, Els [5 ]
Sastre, Xavier [1 ]
机构：
[1] Inst Curie, Paris, France
[2] SeqOmics, Szeged, Hungary
[3] Ctr Gyneacol Oncol, Amsterdam, Netherlands
[4] Inst Oncol Moldova, Kishinev, Moldova
[5] Erasmus MC, Rotterdam, Netherlands
来源：
CURRENT PHARMACEUTICAL DESIGN | 2013年 / 19卷 / 08期
关键词：
Cervical cancer; HPV; vaccines; omics; targeted therapy; SQUAMOUS-CELL CARCINOMA; COLONY-STIMULATING FACTOR; PHASE PROTEIN MICROARRAYS; TUMOR-SUPPRESSOR PROTEIN; HUMAN-PAPILLOMAVIRUS DNA; GROWTH-FACTOR RECEPTOR; IGF-BINDING PROTEIN-3; C-MET; FACTOR-I; CONCURRENT CHEMORADIATION;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Cervical cancer is the second most common malignancy among women worldwide. While more than 90% of cervical cancers carry one or more high risk HPV types, the exact relationship between HPV oncoproteins and signaling pathways alterations in cervical cancer remains to be clarified. Vaccines and targeted therapies are today considered of great potential for the improvement of patients' outcome. This review will focus on the interaction of HPV with cervical cancer pathway activations. Next generation high throughput screening technologies for molecular and protein profiling as well as innovative logistics, necessary for the implementation of the personalized care of cervical cancer patients will be discussed.
引用
收藏
页码：1379 / 1394
页数：16
相关论文
共 50 条
  • [21] Does HPV Type Matter in Cervical Squamous Cell Carcinoma: Transcriptomic Immune Profiling
    Wallbillich, John
    Wu, Sharon
    Bandyopadhyay, Sudeshna
    Corey, Logan
    Abada, Evi
    Kheil, Mira
    Tawil, Tala
    Jain, Deepti
    Huang, Marilyn
    Thaker, Premal
    Jones, Nathaniel
    Korn, W. Michael
    Oberley, Matthew
    Spetzler, David
    Morris, Robert
    Ali-Fehmi, Rouba
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 844 - 845
  • [22] Does HPV Type Matter in Cervical Squamous Cell Carcinoma: Transcriptomic Immune Profiling
    Wallbillich, John
    Wu, Sharon
    Bandyopadhyay, Sudeshna
    Corey, Logan
    Abada, Evi
    Kheil, Mira
    Tawil, Tala
    Jain, Deepti
    Huang, Marilyn
    Thaker, Premal
    Jones, Nathaniel
    Korn, W. Michael
    Oberley, Matthew
    Spetzler, David
    Morris, Robert
    Ali-Fehmi, Rouba
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 844 - 845
  • [23] Transcriptomic immune profiling for cervical squamous cell carcinoma: Does HPV type matter?
    Wallbillich, John
    Wu, Sharon
    Corey, Logan
    Kheil, Mira
    Gogoi, Radhika
    Huang, Marilyn
    Jones, Nathaniel
    Spetzler, David
    Thaker, Premal
    Herzog, Thomas
    Korn, W. Michael
    Morris, Robert
    Winer, Ira
    Ali-Fehmi, Rouba
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S100 - S100
  • [24] Human Papillomavirus and Cervical Dysplasia in Latinas: Evaluating the Association Between HPV Infection and Cervical Dysplasia
    Fanucchi, Hannah
    Naresh, Amber
    OBSTETRICS AND GYNECOLOGY, 2022, 139 : 29S - 29S
  • [25] HPV and non-HPV related squamous cell carcinoma of the oropharynx
    Woods, R. S. R.
    Keegan, H.
    Tewari, P.
    Toner, M.
    Kennedy, S.
    O'Regan, E.
    Martin, C.
    O'Leary, J. J.
    Timon, C. V.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 : S112 - S112
  • [26] Is there a need for screening of cervical HPV infections and carcinoma?
    Miyagi, Etsuko
    Mizushima, Taichi
    BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2024, 96
  • [27] Genomic changes and HPV type in cervical carcinoma
    Matthews, CP
    Shera, KA
    McDougall, JK
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 2000, 223 (03): : 316 - 321
  • [28] HPV DNA in plasma of patients with cervical carcinoma
    Sathish, N
    Abraham, P
    Peedicayil, A
    Sridharan, G
    John, S
    Shaji, RV
    Chandy, G
    JOURNAL OF CLINICAL VIROLOGY, 2004, 31 (03) : 204 - 209
  • [29] Cytokine release in HR-HPV(+) women without and with cervical dysplasia (CIN II and III) or carcinoma, compared with HR-HPV(-) controls
    Bais, Aagje G.
    Beckmann, Ilse
    Ewing, Patricia C.
    Eijkemans, Marinus J. C.
    Meijer, Chris J. L. M.
    Snijders, Peter J. F.
    Helmerhorst, Theo J. M.
    MEDIATORS OF INFLAMMATION, 2007, 2007
  • [30] HUMAN PAPILLOMA-VIRUS (HPV) INFECTION RELATED TO ORAL EPITHELIAL DYSPLASIA AND CARCINOMA
    HILLE, JJ
    ALTINI, M
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1986, 15 (07) : 394 - 394
12345